Literature DB >> 22818876

Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.

Richelle N Olsen1, Douglas Woelkers, Rebecca Dunsmoor-Su, D Yvette Lacoursiere.   

Abstract

OBJECTIVE: We sought to determine the association of abnormal second-trimester serum analytes with early preterm preeclampsia. STUDY
DESIGN: We conducted a retrospective study of 7767 subjects undergoing second-trimester serum aneuploidy screening. Values of maternal serum α-fetoprotein (AFP), β-human chorionic gonadotropin (hCG), and inhibin (INH) were calculated as multiples of the median (MoM) and evaluated by gestational age at delivery and occurrence of preeclampsia.
RESULTS: Of 459 (6.5%) cases of preeclampsia, 65 (14%) delivered <34 weeks and 394 (86%) delivered >34 weeks. Elevated AFP, hCG, and INH >2 MoM were associated with preeclampsia, and the odds ratio was higher for the development of preeclampsia <34 weeks than >34 weeks (odds ratio, 8.04 vs 2.91 for AFP, 3.6 vs 2 for hCG, and 4.17 vs 3.08 for INH, P < .001 for all). The higher the MoM for each analyte the greater the likelihood of preeclampsia.
CONCLUSION: Elevated AFP, hCG, and INH levels >2 MoM are associated with developing early preeclampsia, and the more elevated they are, the higher the likelihood.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818876     DOI: 10.1016/j.ajog.2012.06.006

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

Review 1.  Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends.

Authors:  Jia Liu; Babak Mosavati; Andrew V Oleinikov; E Du
Journal:  Transl Res       Date:  2019-05-20       Impact factor: 7.012

2.  Population-based biomarker screening and the development of severe preeclampsia in California.

Authors:  Véronique Taché; Rebecca J Baer; Robert J Currier; Chin-Shang Li; Dena Towner; L Elaine Waetjen; Laura L Jelliffe-Pawlowski
Journal:  Am J Obstet Gynecol       Date:  2014-03-14       Impact factor: 8.661

3.  Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin.

Authors:  A G Euser; T D Metz; A A Allshouse; K D Heyborne
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

4.  Simultaneous use of Tumor Necrosis Factor, Lipid Profile, and β-hCG As Markers of Severity of Preeclampsia.

Authors:  Reham Elazab; Mostafa Alkhiary; Mohamed Bedairi; Alaa Wageh
Journal:  J Obstet Gynaecol India       Date:  2021-09-24

5.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

6.  Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Authors:  Tim I M Korevaar; Eric A P Steegers; Yolanda B de Rijke; Sarah Schalekamp-Timmermans; W Edward Visser; Albert Hofman; Vincent W V Jaddoe; Henning Tiemeier; Theo J Visser; Marco Medici; Robin P Peeters
Journal:  Eur J Epidemiol       Date:  2015-05-12       Impact factor: 8.082

Review 7.  The Prenatal Hormone Milieu in Autism Spectrum Disorder.

Authors:  Whitney Worsham; Susan Dalton; Deborah A Bilder
Journal:  Front Psychiatry       Date:  2021-07-01       Impact factor: 4.157

8.  Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.

Authors:  Alessandro Rolfo; Domenica Giuffrida; Anna Maria Nuzzo; Daniele Pierobon; Simona Cardaropoli; Ettore Piccoli; Mirella Giovarelli; Tullia Todros
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast.

Authors:  Angela Pham; Jun Zhang; Liping Feng
Journal:  Reprod Toxicol       Date:  2020-11-02       Impact factor: 3.421

10.  Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia.

Authors:  Mihaela Daniela Oancea; Nicolae Costin; Daria Maria Pop; Razvan Ciortea; Dan Mihu
Journal:  Clujul Med       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.